Viktor Grünwald, MD, PhD, University Hospital Essen, Essen Germany, discusses a session at ESMO 2023, where open questions in urothelial carcinoma were debated. Dr Grünwald elaborates on the current utilization of treatments and using avelumab as a maintenance therapy depending on patient subgroups. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.